Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN)

被引:34
作者
Moroni, Gabriella [1 ]
Gallelli, Beniamina [1 ]
Quaglini, Silvana [2 ]
Leoni, Antonio [1 ]
Banfi, Giovanni [1 ]
Passerini, Patrizia [1 ]
Montagnino, Giuseppe [1 ]
Messa, Piergiorgio [1 ]
机构
[1] Fdn Osped Maggiore, Div Nefrol & Dialisi, Mangiagalli, Regina Elena Mi, Italy
[2] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy
关键词
membranous nephropathy; recurrent glomerulonephritis; renal transplantation; KIDNEY-TRANSPLANTATION; RECURRENT GLOMERULONEPHRITIS; RISK-FACTORS; DE-NOVO; NEPHROPATHY; ALLOGRAFT; RITUXIMAB; GLOMERULOPATHY; DISEASE; CYCLOSPORINE;
D O I
10.1093/ndt/gfq223
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. The outcomes of 35 first renal transplants performed between 1975 and 2008 in patients with MN were compared with those of 70 controls transplanted in the same period and matched for sex, age and source of donors. Results. The mean post-transplant follow-up was 117 +/- 86 months for MN patients and 123 +/- 83 months for controls. At 15 years, patient survival was 96% in patients with MN and 88% in the controls (P = ns), while graft survival rates were respectively 40% and 69% (P = 0.06). MN recurred in 12 patients (34%), namely in 4/8 (50%) patients who received the kidney from related living donors and in 8/27 (29.6%) who received the kidney from a deceased donor. Recurrence led to graft failure in six patients, all deceased donor kidney recipients, within 54 +/- 33 months. The other six grafts are functioning 134 +/- 73 months after transplantation. Patients with recurrence were more frequently females (42% vs 4.3%, P = 0.02). The recurrence occurred earlier (4.8 +/- 3.0 vs 45.6 +/- 46.9 months, P = 0.05), and there was a trend to develop a higher proteinuria (7.1 +/- 5.5 vs 3.67 +/- 2.6 g/24 h, P = 0.1) in grafts eventually lost because of recurrence. Conclusions. The long-term patient survival was similar in renal transplant recipients with MN and in controls. The graft survival was lower in MN patients than in controls, although the difference was at borderline significance. Recurrence occurred in one-third of the patients and caused graft loss in half of them.
引用
收藏
页码:3408 / 3415
页数:9
相关论文
共 26 条
[1]   Significance and Management of Proteinuria in Kidney Transplant Recipients [J].
Amer, Hatem ;
Cosio, Fernando G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12) :2490-2492
[2]   DENOVO AND RECURRENT MEMBRANOUS GLOMERULOPATHY FOLLOWING KIDNEY-TRANSPLANTATION [J].
BERGER, BE ;
VINCENTI, F ;
BIAVA, C ;
AMEND, WJ ;
FEDUSKA, N ;
SALVATIERRA, O .
TRANSPLANTATION, 1983, 35 (04) :315-319
[3]   Risk of renal allograft loss from recurrent glomerulonephritis [J].
Briganti, EM ;
Russ, GR ;
McNeil, JJ ;
Atkins, C ;
Chadban, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (02) :103-109
[4]   Initial response to immunosuppressive and renoprotective treatment in posttransplant glomerulonephritis [J].
Carneiro-Roza, F. ;
Medina-Pestana, J. O. ;
Moscoso-Solorzano, G. ;
Franco, M. ;
Ozaki, K. ;
Mastroianni-Kirsztajn, G. .
TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) :3491-3497
[5]   Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial [J].
Cattran, DC ;
Appel, GB ;
Hebert, LA ;
Hunsicker, LG ;
Pohl, MA ;
Hoy, WE ;
Maxwell, DR ;
Kunis, CL .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1484-1490
[6]  
Cosyns JP, 1998, CLIN NEPHROL, V50, P144
[7]  
COUCHOUD C, 1995, TRANSPLANTATION, V59, P1275
[8]   RECURRENCE OF IDIOPATHIC MEMBRANOUS NEPHROPATHY IN A RENAL-ALLOGRAFT [J].
CROSSON, JT ;
WATHEN, RL ;
RAIJ, L ;
ANDERSEN, RC ;
ANDERSON, WR .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (08) :1101-1106
[9]   Recurrent idiopathic membranous nephropathy after kidney transplantation: A surveillance biopsy study [J].
Dabade, T. S. ;
Grande, J. P. ;
Norby, S. M. ;
Fervenza, F. C. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (06) :1318-1322
[10]   Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-CD20 Monoclonal Antibodies [J].
El-Zoghby, Ziad M. ;
Grande, Joseph P. ;
Fraile, M. G. ;
Norby, S. M. ;
Fervenza, F. C. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (12) :2800-2807